DCGI

icmr

Government Explains ICMR’s Letter Giving August 15 Deadline For COVID-19 Vaccine Launch

Days after uproar over ICMR Director General’s letter envisaging the launch of COVID-19 vaccine by August 15, Union Health Ministry officials have now clarified that the intent of the letter was “only to expedite duly approved clinical trials without compromising on safety and security concerns.” The Drugs Controller General of India (DCGI) has permitted two …

Government Explains ICMR’s Letter Giving August 15 Deadline For COVID-19 Vaccine Launch Read More »

Glenmark Launches COVID-19 Drug FabiFlu After DCGI Nod

Glenmark Pharmaceuticals has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19. The company has received manufacturing and marketing approval from the Drugs Controller General of India (DCGI) yesterday. FabiFlu is the first oral Favipiravir-approved medication for the treatment of COVID-19, the company said in …

Glenmark Launches COVID-19 Drug FabiFlu After DCGI Nod Read More »

Covid-19: DCGI Approves Emergency Use Of Gilead’s Remdesivir

Drug Controller General of India V.G. Somani has approved the use of Gilead Sciences Inc’s novel drug remdesivir to treat covid-19 patients, Lav Aggarwal, joint secretary in the health ministry said. “The DCGI gave an emergency use permission for remdesivir… and this was based on evidence that was provided by the company to support its …

Covid-19: DCGI Approves Emergency Use Of Gilead’s Remdesivir Read More »

Zydus Cadila Gets DCGI Nod For Saroglitazar To Treat Liver Disease

Drugs maker Zydus Cadila on Thursday said it has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver, commonly known as NASHin India. The Ahmedabad-based company said the approved product is the first ever drugany where in the world for …

Zydus Cadila Gets DCGI Nod For Saroglitazar To Treat Liver Disease Read More »